Advanced search
Publication Cover
Pharmacogenomics Volume 11, 2010 - Issue 3
Submit an article Journal homepage
200
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Preoperative Survivin mRNA Detection in Peripheral Blood is an Independent Predictor of Outcome in Esophageal Carcinoma

Andreas-Claudius Hoffmann1 Department of Medicine (Cancer Research), Molecular Oncology Risk-Profile Evaluation (MORE), West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, Essen, 45147, Germany.Correspondence[email protected]
,
Daniel Vallböhmer2 Department of General, Visceral & Cancer Surgery, University of Cologne, Cologne, Germany
,
Peter Grimminger2 Department of General, Visceral & Cancer Surgery, University of Cologne, Cologne, Germany
,
Ralf Metzger2 Department of General, Visceral & Cancer Surgery, University of Cologne, Cologne, Germany
,
Klaus L Prenzel2 Department of General, Visceral & Cancer Surgery, University of Cologne, Cologne, Germany
,
Arnulf H Hoelscher2 Department of General, Visceral & Cancer Surgery, University of Cologne, Cologne, Germany
&
Jan Brabender2 Department of General, Visceral & Cancer Surgery, University of Cologne, Cologne, Germany
 show all
Pages 341-347 | Published online: 17 Mar 2010

Bibliography

  • Holscher AH , VallböhmerD: [Surgical treatment of esophageal tumors including local ablation].Zentralbl. Chir.132(2) , W18–W36; quiz W37–W38 (2007).
  • Lordick F , OttK, NovotnyA, SchuhmacherC, SiewertJR: [R1 resection in the surgery of upper gastrointestinal tumors: relevance and therapeutic consequences].Chirurg78(9) , 792–801 (2007).
  • Metzger R , DrebberU, BaldusSE, MonigSP, HolscherAH, BollschweilerE: Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.Ann. Surg. Oncol.16(2) , 447–453 (2009).
  • Heitmiller RF : Epidemiology, diagnosis, and staging of esophageal cancer.Cancer Treat. Res.105 , 375–386 (2001).
  • Schneider PM , BaldusSE, MetzgerR et al.: Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.Ann. Surg.242(5) , 684–692 (2005).
  • Wong R , MalthanerR: Esophageal cancer: a systematic review.Curr. Probl. Cancer.24(6) , 297–373 (2000).
  • Stahl M , OliveiraJ: Esophageal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann. Oncol.19(Suppl. 2) , II21–II22 (2008).
  • Melis M , McLoughlinJM, DeanEM et al.: Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.J. Surg. Res.153(1) , 114–120 (2008).
  • Tsujimoto H , OnoS, ChochiK, SugasawaH, IchikuraT, MochizukiH: Preoperative chemoradiotherapy for esophageal cancer enhances the postoperative systemic inflammatory response.Jpn. J. Clin. Oncol.36(10) , 632–637 (2006).
  • Smithers BM , CullinanM, ThomasJM et al.: Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy.Dis. Esophagus20(6) , 471–477 (2007).
  • Urba SG , OrringerMB, TurrisiA, IannettoniM, ForastiereA, StrawdermanM: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.J. Clin. Oncol.19(2) , 305–313 (2001).
  • Swisher SG , HolmesEC, HuntKK, DotyJE, ZinnerMJ, McFaddenDW: The role of neoadjuvant therapy in surgically resectable esophageal cancer.Arch. Surg.131(8) , 819–824; discussion 24–25 (1996).
  • Lordick F , EbertM, SteinHJ: Current treatment approach to locally advanced esophageal cancer: is resection mandatory?Future Oncol.2(6) , 717–721 (2006).
  • Hoffmann AC , Warnecke-EberzU, LuebkeT et al.: Survivin mRNA in peripheral blood is frequently detected and significantly decreased following resection of gastrointestinal cancers.J. Surg. Oncol.95(1) , 51–54 (2007).
  • Brabender J , VallböhmerD, GrimmingerP et al.: ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus.J. Gastrointest. Surg.12(11) , 1815–1821 (2008).
  • Reed JC : The survivin saga goes in vivo.J. Clin. Invest.108(7) , 965–969 (2001).
  • Ambrosini G , AdidaC, AltieriDC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.Nat. Med.3(8) , 917–921 (1997).
  • Weiss C , von Romer F, Capalbo G et al.: Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy. Int. J. Radiat. Oncol. Biol. Phys.74(5) , 1455–1460 (2009).
  • Hsu KF , LinCK, YuCP et al.: Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.Dis. Esophagus22(5) , 402–408 (2009).
  • Vallböhmer D , KuhnE, Warnecke-EberzU et al.: Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.Pharmacogenomics9(6) , 681–690 (2008).
  • Sobin LH , FlemingID: TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer.Cancer80(9) , 1803–1804 (1997).
  • Lu KH , PattersonAP, WangL et al.: Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.Clin. Cancer Res.10(10) , 3291–3300 (2004).
  • Hoffman AC , DanenbergKD, TaubertH, DanenbergPV, WuerlP: A three-gene signature for outcome in soft tissue sarcoma.Clin. Cancer Res.15(16) , 5191–5198 (2009).
  • Hoffmann AC , MoriR, VallböhmerD et al.: High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.Neoplasia10(7) , 674–679 (2008).
  • Rohatgi PR , SwisherSG, CorreaAM et al.: Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus.Int. J. Gastrointest. Cancer36(2) , 69–76 (2005).
  • Bollschweiler E , WolfgartenE, GutschowC, HolscherAH: Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.Cancer92(3) , 549–555 (2001).
  • Siewert JR , OttK: Are squamous and adenocarcinomas of the esophagus the same disease?Semin. Radiat. Oncol.17(1) , 38–44 (2007).
  • Khan Z , TiwariRP, MulherkarR et al.: Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.Head Neck31(8) , 1039–1048 (2009).
  • Cohen SJ , AlpaughRK, GrossS et al.: Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.Clin. Colorectal Cancer6(2) , 125–132 (2006).
  • Hiraiwa K , TakeuchiH, HasegawaH et al.: Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.Ann. Surg. Oncol.15(11) , 3092–3100 (2008).
  • Schwarzenbach H , Alix-PanabieresC, MullerI et al.: Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.Clin. Cancer Res.15(3) , 1032–1038 (2009).
  • Lurje G , SchiesserM, ClaudiusA, SchneiderPM: Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications.J. Oncol.2010 , 392652 (2010).
  • Grimminger P , VallböhmerD, HoffmannA et al.: Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer.J. Surg. Oncol.100(6) , 447–451 (2009).
  • Cao M , YieSM, WuSM et al.: Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance.Clin. Exp. Metastasis26(7) , 751–758 (2009).
  • Yie SM , LouB, YeSR et al.: Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.Ann. Surg. Oncol.15(11) , 3073–3082 (2008).
  • Yie SM , LouB, YeSR et al.: Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.Lung Cancer63(2) , 284–290 (2009).
  • Yie SM , LuoB, YeNY, XieK, YeSR: Detection of survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.Clin. Exp. Metastasis23(5–6) , 279–289 (2006).
  • Warnecke-Eberz U , HokitaS, XiH et al.: Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.Oncol. Rep.13(6) , 1241–1246 (2005).
  • Klein CA : Cancer. The metastasis cascade.Science321(5897) , 1785–1787 (2008).
  • Ling X , BernackiRJ, BrattainMG, LiF: Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.J. Biol. Chem.279(15) , 15196–15203 (2004).
  • Kim JY , ChungJY, LeeSG et al.: Nuclear interaction of Smac/DIABLO with survivin at G2/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells.Biochem. Biophys. Res. Commun.350(4) , 949–954 (2006).
  • Chandele A , PrasadV, JagtapJC, ShuklaR, ShastryPR: Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis.Neoplasia6(1) , 29–40 (2004).
  • Beardmore VA , AhonenLJ, GorbskyGJ, KallioMJ: Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity.J. Cell Sci.117(Pt 18) , 4033–4042 (2004).
  • Ghossein RA , BhattacharyaS, RosaiJ: Molecular detection of micrometastases and circulating tumor cells in solid tumors.Clin. Cancer Res.5(8) , 1950–1960 (1999).
  • Ghossein RA , CoitD, BrennanM et al.: Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma.Clin. Cancer Res.4(2) , 419–428 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.